SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $101,094 | -55.1% | 11,620 | -17.3% | 0.00% | – |
Q4 2021 | $225,000 | -14.4% | 14,056 | -1.5% | 0.00% | – |
Q3 2021 | $263,000 | +17.9% | 14,276 | -10.4% | 0.00% | – |
Q2 2021 | $223,000 | +12.6% | 15,941 | +18.5% | 0.00% | – |
Q1 2021 | $198,000 | -23.6% | 13,457 | +0.7% | 0.00% | – |
Q4 2020 | $259,000 | +2490.0% | 13,366 | +1913.0% | 0.00% | – |
Q2 2018 | $10,000 | 0.0% | 664 | -8.5% | 0.00% | – |
Q1 2018 | $10,000 | -23.1% | 726 | -35.6% | 0.00% | – |
Q4 2017 | $13,000 | – | 1,128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |